Paul Whitaker Selected Research

Piperacillin

1/2018	β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells.
12/2017	Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.
6/2013	β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
8/2012	Nonimmediate β-lactam reactions in patients with cystic fibrosis.
6/2012	Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.
7/2011	Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Whitaker Research Topics

Disease

13	Cystic Fibrosis (Mucoviscidosis) 03/2021 - 06/2010
12	Hypersensitivity (Allergy) 01/2020 - 06/2010
4	Drug Hypersensitivity (Drug Allergy) 01/2020 - 08/2012
2	Tuberculosis (Tuberculoses) 01/2018 - 01/2017
2	Chemical and Drug Induced Liver Injury 10/2016 - 01/2015
1	Lung Diseases (Lung Disease) 03/2021
1	Respiratory Insufficiency (Respiratory Failure) 03/2021
1	Disease Progression 01/2020
1	Mycoses (Diseases, Fungus) 02/2018
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2018
1	Iatrogenic Disease 01/2017
1	Liver Failure 11/2016
1	Infections 06/2012
1	Allergic Bronchopulmonary Aspergillosis 01/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2002

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2020 - 01/2002
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 06/2010
7	LactamsIBA 01/2019 - 06/2012
6	Piperacillin FDA LinkGeneric 01/2018 - 07/2011
6	AntigensIBA 01/2018 - 06/2010
3	Sulfamethoxazole FDA LinkGeneric 10/2019 - 06/2010
2	Penicillins (Penicillin)FDA Link 12/2017 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2015
2	HaptensIBA 01/2017 - 08/2012
1	beta-LactamsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	AntibodiesIBA 12/2017
1	Immunoglobulin G (IgG)IBA 12/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2017
1	AerosolsIBA 12/2016
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 10/2016
1	Amoxicillin (Wymox)FDA LinkGeneric 10/2016
1	tetrazepam (Panos)IBA 04/2016
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2016
1	AlbuminsIBA 06/2013
1	Aztreonam FDA LinkGeneric 06/2013
1	Meropenem (Merrem)FDA LinkGeneric 06/2013
1	Human Serum Albumin FDA LinkGeneric 06/2013
1	Voriconazole (Vfend)FDA LinkGeneric 10/2011
1	EnzymesIBA 06/2011
1	SulfonamidesIBA 06/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	Interleukin-10 (Interleukin 10)IBA 06/2011
1	Interleukin-17 (Interleukin 17)IBA 06/2011
1	dornase alfa (Pulmozyme)FDA Link 01/2011
1	FibrinIBA 01/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2002
1	Metformin (Glucophage)FDA LinkGeneric 01/2002

Therapy/Procedure

5	Therapeutics 03/2021 - 06/2010
1	Noninvasive Ventilation 03/2021
1	Nursing Care 01/2020